merieux inactivated rabies vaccine
sanofi-aventis australia pty ltd - rabies virus -
typhim vi
sanofi-aventis australia pty ltd - salmonella typhi vi polysaccharide -
surgam sa
sanofi-aventis new zealand limited - tiaprofenic acid 300mg - modified release capsule - 300 mg - active: tiaprofenic acid 300mg
imovax polio injection
sanofi-aventis singapore pte. ltd. - inactivated poliomyelitis virus type 1 (mahoney); inactivated poliomyelitis virus type 2 (mef-1); inactivated poliomyelitis virus type 3 (saukett) - injection - 8 d.u. - inactivated poliomyelitis virus type 1 (mahoney) 40 d.u./0.5 ml; inactivated poliomyelitis virus type 2 (mef-1) 8 d.u./0.5 ml; inactivated poliomyelitis virus type 3 (saukett) 32 d.u./0.5 ml
ticlid tablet 250 mg (film-coated)
sanofi-aventis singapore pte. ltd. - ticlopidine hcl - tablet, film coated - 250 mg
imogam rabies pasteurized human rabies immunoglobulin 150 iu/ml injection vial
sanofi-aventis australia pty ltd - rabies immunoglobulin, quantity: 150 iu/ml - injection - excipient ingredients: glycine; sodium chloride; water for injections - imogam rabies pasteurized is indicated in subjects who are thought to have been exposed to rabies virus, especially cases of major exposure, in accordance with w.h.o. recommendations as specified in the international product information.
epilim 200 enteric-coated tablet
sanofi-aventis (malaysia) sdn. bhd. - sodium valproate -
adenoscan
sanofi-aventis australia pty ltd - adenosine -
stamaril
sanofi-aventis australia pty ltd - yellow fever virus -
surgam
sanofi-aventis australia pty ltd - tiaprofenic acid -